Neuronal endocytic pathway activation is a specific and very early response in AD that precedes amyloid-beta (Aβ) deposition in sporadic AD, hence, the role of dysregulated Rab5 in AD has been extensively studied and reviewed elsewhere [1,48,70,71]. The gene discussed is RAB5A; the disease is Alzheimer disease.